Entity Common Stock, Shares Outstanding of Amneal Pharmaceuticals, Inc. from 09 Mar 2018 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Amneal Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 Mar 2018 to 13 Feb 2026.
  • Amneal Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 314,629,101, a 1.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Amneal Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 314,629,101 +4,662,760 +1.5% 13 Feb 2026 10-K 27 Feb 2026 2025 FY
Q3 2025 314,362,920 +4,518,490 +1.5% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 314,079,309 +4,536,701 +1.5% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 313,419,599 +4,768,226 +1.5% 30 Apr 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 309,966,341 14 Feb 2025 10-K 28 Feb 2025 2024 FY
Q3 2024 309,844,430 31 Oct 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 309,542,608 31 Jul 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 308,651,373 30 Apr 2024 10-Q 08 May 2024 2024 Q1
Q1 2018 1,000* 09 Mar 2018 10-K 09 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.